Citigroup »

Kalvista Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5M 282k 12.24
2023-09-30 $2.7M 277k 9.63
2023-03-31 $2.2M 277k 7.86
2022-12-31 $1.9M 277k 6.76
2022-09-30 $10k 669 14.95
2021-12-31 $716k 54k 13.23
2021-03-31 $634k 25k 25.68
2020-12-31 $68k 3.6k 19.02
2020-09-30 $12k 918 13.07
2020-06-30 $28k 2.3k 12.28
2020-03-31 $30k 3.9k 7.72
2019-12-31 $45k 2.5k 17.79
2019-09-30 $6.1k 579 10.49
2019-06-30 $72k 3.3k 22.16
2019-03-31 $350k 12k 28.60